Most hospital executives think they have a clear picture of pharmacy performance. The reports are there. The numbers look stable.
Yet, internal reporting only shows what’s being tracked, not what’s being missed or overlooked.
A pharmacy performance assessment reveals what’s hidden beneath those reports. Everything from cost leakage and compliance risk to operational gaps that don’t surface until they become problems.
What is a Pharmacy Performance Assessment?
A pharmacy performance assessment is a focused, multi-day evaluation that’s designed to identify financial, operational, and compliance gaps within a hospital pharmacy.
At CompleteRx, we offer three types of assessments:
- Full performance
- Regulatory and compliance
- 340B program review
- Pharmacy technology reviews
- CDM reviews
Each of these assessments is customized to uncover specific risks and opportunities. The goal is to surface actionable findings that internal reporting often misses, rather than generating more data. Once that’s complete, the next step is to deliver a clear path forward for your organization’s leadership.
Learn more about pharmacy performance assessment.
Five Things a Pharmacy Assessment Commonly Uncovers
1. Drug Cost Leakage in Purchasing and Formulary
The majority of hospitals track total drug spend. Yet only the minority understands where that spending is quietly leaking.
Assessments frequently uncover gaps in generic substitution, formulary drift, and purchasing inefficiencies. For instance, a hospital carrying $5M in inventory at six turns per year compared to the industry benchmark of twelve is essentially sitting on $2.5M in tied-up cash.
In one rural 25-bed critical access hospital, improving inventory discipline freed up $51,000 in cash in the first month, reduced inventory levels by 20%, and boosted 340B program savings over the following year.
It’s these types of insights that are often validated against broader hospital pharmacy benchmarks and operational patterns tied to hospital pharmacy inventory management, where small inefficiencies can compound into significant financial loss.
2. Compliance Gaps that Haven’t Triggered a Citation-Yet
The danger of regulatory risk is that it rarely announces itself in advance. Instead, it tends to show up during a survey.
Assessments consistently identify a wide range of operational and regulatory compliance risks that often go unnoticed during routine internal reviews. These can include documentation gaps, outdated protocols, inconsistencies in medication handling, and broader process vulnerabilities that may create significant regulatory exposure if left unaddressed. Some of the most common issues that have been uncovered during a pharmacy assessment involve:
- DEA compliance requirements, including controlled substance recordkeeping and storage security.
- USP 797 and USP 800 compliance related to sterile compounding environments, equipment, and processes.
- Board of Pharmacy regulatory compliance concerns that can span a variety of operational areas across a department.
While most of these issues are ultimately correctable internally, they’re often difficult for pharmacy teams, already pushed to the limit, to proactively identify and resolve without dedicated assessment and oversight.
By using internal benchmarking methods, CompleteRx can identify where a pharmacy is operating below established standards before regulators do.
3. Revenue Sitting in Billing Inefficiencies
Missed opportunities for reimbursement are among the most overlooked areas in a hospital pharmacy.
From infusion billing errors and incomplete charge capture to specialty script leakage, these mistakes frequently fall between pharmacy and finance. These are not isolated issues; rather, they’re systemic process gaps.
At one freestanding infusion center in Texas that performs 5,700 infusions annually, billing inefficiencies tied to IVIG treatments were identified and corrected. As a result, monthly write-offs dropped by nearly 40%, thereby unlocking meaningful gains in pharmacy revenue growth.
In addition, aggregate claims data also consistently reveal out-of-network script leakage, meaning prescriptions that should be filled in-house but are not. This represents another significant source of recoverable revenue.
4. 340B Eligibility Gaps That Are Already Costing Money
Non-registered prescriber location claims are among the most common findings in 340B leakage.
These prescriptions may appear routine, but they can quietly disqualify eligible claims and expose your organization to potential clawbacks. Most hospitals are unable to detect this internally. Instead, it’s learned during an audit or as an assessment.
Claims data analysis routinely reveals these gaps, along with other compliance risks that directly impact a hospital’s margin. Strengthening pharmacy cost control at this level directly protects both financial performance and its regulatory standing.
5. Staffing Models that Look Efficient But Carry Risk
On paper, staffing may appear optimized. However, in practice, it often isn’t.
Effective assessments reveal workload imbalances, role misalignment, and training gaps that regularly don’t show up in labor cost reports. Staff may be operating outside their optimal scope or compensating for process inefficiencies. Either way, this is more than an operational concern; it directly affects patient safety, readiness for compliance, and long-term sustainability.
What a Pharmacy Assessment Uncovered at One Community Hospital
A 150-bed community hospital in the northeastern U.S. began working with CompleteRx for a full on-site assessment. The partnership was not due to the hospital underperforming, but rather leadership seeking clarity.
From the outside, pharmacy operations appeared stable and efficient. It was within expected ranges, and no immediate compliance concerns were noted. In essence, there was no indication that anything was wrong internally.
Yet, what they discovered was completely unexpected.
Within days, the assessment uncovered over $ 417,210 in drug cost-saving opportunities. They weren’t linked to a single issue, but to a series of small, compounding gaps across purchasing strategy, IV-to-PO conversion, antimicrobial stewardship, therapeutic interchange, and clinical guideline alignment.
Individually, none of these gaps raised a red flag. But together, they represented a large, recoverable opportunity that internal reporting had never highlighted.
This wasn’t a turnaround story, and the hospital certainly wasn’t in distress. Instead, it was a visibility gap, one that had been quietly affecting financial performance undetected for a significant period.
See the complete breakdown in this clinical drug savings optimization case study.
If your pharmacy performance looks stable on paper, it may be time to question what lies beneath it.
What You Walk Away With
A pharmacy performance assessment delivers more than a report.
Executive leadership receives:
- A clear breakdown of financial, operational, and compliance gaps
- Benchmark-informed insights based on real-world performance standards
- A defined, actionable roadmap for improvement
- A commitment to measurable cost savings
The findings are presented directly to the C-suite, ensuring alignment and accountability from the start.
See What your Assessment Uncovers
The majority of hospitals aren’t underperforming, in part, because of what they see. They’re underperforming because of what they don’t. A CompleteRx pharmacy performance assessment is complimentary, completed in three days, and designed to uncover the opportunities your internal reports miss.
Explore how hospital pharmacy management can transform performance.
Schedule my assessment
Frequently Asked Questions About Pharmacy Performance Assessments
What is a pharmacy performance assessment?
A pharmacy performance assessment is a structured evaluation of a hospital pharmacy’s financial, operational, and compliance performance. At CompleteRx, assessments are completed within three days and are designed to surface gaps that internal reporting typically misses, from drug cost leakage and 340B eligibility issues to staffing inefficiencies and billing errors.
How long does a pharmacy performance assessment take?
A CompleteRx pharmacy performance assessment is completed within 1-3 days. Findings are then compiled and presented directly to executive leadership, giving your team a clear picture of where the pharmacy stands and a defined path forward.
What does a pharmacy performance assessment typically uncover?
The most common findings include drug cost leakage in purchasing and formulary management, compliance exposures that haven’t yet triggered a citation, revenue loss from billing inefficiencies, and staffing models that carry more risk than labor reports reflect. Assessments may also identify missed opportunities related to 340B program eligibility and optimization for participating hospitals. Most hospitals are surprised by what the assessment surfaces, not because something is wrong, but because internal reporting wasn’t built to find it.
How much does a pharmacy performance assessment cost?
CompleteRx offers a complimentary pharmacy performance assessment at no cost to your organization. For hospitals seeking a deeper operational evaluation, there is also an option for a comprehensive paid assessment, typically valued between $25,000 and $50,000 depending on the size and complexity of the facility.
Who conducts the assessment?
Assessments are conducted by a team of licensed CompleteRx pharmacy subject matter experts with direct experience managing hospital pharmacies. Findings are presented to your C-suite with context, not just numbers.
Is a pharmacy performance assessment only for underperforming pharmacies?
No. Many hospitals that request an assessment are already operating well on paper. The value is in the visibility. A stable-looking pharmacy can still carry recoverable cost opportunities, compliance gaps, or revenue inefficiencies that don’t surface until someone looks specifically for them.
